These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27475499)

  • 1. Effects of overexpressing FoxO1 on apoptosis in glomeruli of diabetic mice and in podocytes cultured in high glucose medium.
    Li W; Wang Q; Du M; Ma X; Wu L; Guo F; Zhao S; Huang F; Wang H; Qin G
    Biochem Biophys Res Commun; 2016 Sep; 478(2):612-7. PubMed ID: 27475499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
    Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
    Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FoxO1 Promotes Mitophagy in the Podocytes of Diabetic Male Mice via the PINK1/Parkin Pathway.
    Li W; Du M; Wang Q; Ma X; Wu L; Guo F; Ji H; Huang F; Qin G
    Endocrinology; 2017 Jul; 158(7):2155-2167. PubMed ID: 28505239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrasentan alleviates high glucose-induced podocyte injury by the microRNA-21/forkhead box O1 axis.
    Wang J; Shen L; Hong H; Li J; Wang H; Li X
    Eur J Pharmacol; 2019 Jun; 852():142-150. PubMed ID: 30876973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of FOXO1 ameliorates the podocyte epithelial-mesenchymal transition induced by high glucose in vitro and in vivo.
    Du M; Wang Q; Li W; Ma X; Wu L; Guo F; Zhao S; Huang F; Wang H; Qin G
    Biochem Biophys Res Commun; 2016 Mar; 471(4):416-22. PubMed ID: 26902117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGRN acts as a novel regulator of mitochondrial homeostasis by facilitating mitophagy and mitochondrial biogenesis to prevent podocyte injury in diabetic nephropathy.
    Zhou D; Zhou M; Wang Z; Fu Y; Jia M; Wang X; Liu M; Zhang Y; Sun Y; Lu Y; Tang W; Yi F
    Cell Death Dis; 2019 Jul; 10(7):524. PubMed ID: 31285425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA LINC01619 Regulates MicroRNA-27a/Forkhead Box Protein O1 and Endoplasmic Reticulum Stress-Mediated Podocyte Injury in Diabetic Nephropathy.
    Bai X; Geng J; Li X; Wan J; Liu J; Zhou Z; Liu X
    Antioxid Redox Signal; 2018 Aug; 29(4):355-376. PubMed ID: 29334763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of silencing Stat1 on high glucose-induced podocytes injury via Forkhead transcription factor O1-regulated the oxidative stress response.
    Wang H; Zhang Y; Xia F; Zhang W; Chen P; Yang G
    BMC Mol Cell Biol; 2019 Jul; 20(1):27. PubMed ID: 31337338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes.
    Lay AC; Hale LJ; Stowell-Connolly H; Pope RJP; Nair V; Ju W; Marquez E; Rollason R; Hurcombe JA; Hayes B; Roberts T; Gillam L; Allington J; Nelson RG; Kretzler M; Holly JMP; Perks CM; McArdle CA; Welsh GI; Coward RJM
    Diabetologia; 2021 Jul; 64(7):1690-1702. PubMed ID: 33758952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal.
    Hongbo M; Yanjiao D; Shuo W; Kun S; Yanjie L; Mengmeng L
    Biochem Biophys Res Commun; 2021 Mar; 545():46-53. PubMed ID: 33545631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes.
    Xing L; Guo H; Meng S; Zhu B; Fang J; Huang J; Chen J; Wang Y; Wang L; Yao X; Wang H
    Biochem Biophys Res Commun; 2021 Jan; 534():450-456. PubMed ID: 33256980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytes.
    Denhez B; Lizotte F; Guimond MO; Jones N; Takano T; Geraldes P
    J Biol Chem; 2015 Jan; 290(1):350-8. PubMed ID: 25404734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXO1 Overexpression Attenuates Tubulointerstitial Fibrosis and Apoptosis in Diabetic Kidneys by Ameliorating Oxidative Injury via TXNIP-TRX.
    Ji L; Wang Q; Huang F; An T; Guo F; Zhao Y; Liu Y; He Y; Song Y; Qin G
    Oxid Med Cell Longev; 2019; 2019():3286928. PubMed ID: 30962862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
    Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
    J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grem2 mediates podocyte apoptosis in high glucose milieu.
    Wen H; Kumar V; Mishra A; Song S; Aslam R; Hussain A; Wang H; Zhou X; He X; Wu G; Luo H; Lan X; Malhotra A; Singhal PC
    Biochimie; 2019 May; 160():113-121. PubMed ID: 30831151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMEM16A exacerbates renal injury by activating P38/JNK signaling pathway to promote podocyte apoptosis in diabetic nephropathy mice.
    Lian H; Cheng Y; Wu X
    Biochem Biophys Res Commun; 2017 May; 487(2):201-208. PubMed ID: 28392397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRMT1 mediates podocyte injury and glomerular fibrosis through phosphorylation of ERK pathway.
    Zhu Y
    Biochem Biophys Res Commun; 2018 Jan; 495(1):828-838. PubMed ID: 29129692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-770-5p is involved in the development of diabetic nephropathy through regulating podocyte apoptosis by targeting TP53 regulated inhibitor of apoptosis 1.
    Zhang SZ; Qiu XJ; Dong SS; Zhou LN; Zhu Y; Wang MD; Jin LW
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1248-1256. PubMed ID: 30779094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney disease.
    Huang F; Wang Q; Guo F; Zhao Y; Ji L; An T; Song Y; Liu Y; He Y; Qin G
    EBioMedicine; 2019 Oct; 48():491-504. PubMed ID: 31629675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.